Digital
JPM2026: AI diagnostics and translational research, with And...
On the sidelines of JPM2026, pharmaphorum spoke with Andrew Beck, co-founder and CEO at PathAI, about AI diagnostics in pathology.
R&D
Shaping the future of immunodeficiency care, with Dr Jörg Sc...
Dr Jörg Schüttrumpf, Chief Scientific Innovation Officer of Grifols, discusses advancing immunoglobulin (or IG) treatment for immune disorders.
Oncology
Aligning with national efforts to modernise cancer diagnosti...
Andrew Newland, former CEO of ANGLE, explains why live cell liquid biopsies should become standard in oncology.
Patients
Rethinking prescription drug affordability, with Vinay Patel
Vinay Patel, an innovative pharmacist, discuss the intricacies of drug pricing and accessibility in the US.
Digital
An AI supercomputer and discovering next-gen brain disorder ...
Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
